Sponsor or institution
Clinical trials and research at Zhejiang Hisun Pharmaceutical Co. Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Zhejiang Hisun Pharmaceutical Co. Ltd. that are recruiting, in China. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
AST-3424 versus regorafenib for AKR1C3-high advanced liver cancer
This trial tests whether AST-3424 can help people with AKR1C3-high advanced liver cancer who progressed after immune checkpoint inhibitor therapy, compared with regorafenib.
-
Testing HS387 in adults with advanced solid tumors (Phase Ia/Ib)
Doctors are testing a new drug called HS387 to see if it is safe and helps adults with advanced solid tumors who have exhausted or cannot tolerate standard treatments.
Quick answers
How many clinical trials run by Zhejiang Hisun Pharmaceutical Co. Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.